Cargando…
Long‐term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct‐acting antivirals
BACKGROUND AND AIM: Early hepatocellular carcinoma (HCC) recurrence is common, even after achieving hepatitis C virus (HCV) cure. This study was carried out to assess the long‐term trends and predictors of recurrence after HCV cure by direct‐acting antivirals (DAAs). METHODS: This retrospective, mul...
Autores principales: | Ogawa, Eiichi, Nakamuta, Makoto, Furusyo, Norihiro, Kajiwara, Eiji, Dohmen, Kazufumi, Kawano, Akira, Ooho, Aritsune, Azuma, Koichi, Takahashi, Kazuhiro, Satoh, Takeaki, Koyanagi, Toshimasa, Yamashita, Nobuyuki, Ichiki, Yasunori, Yamashita, Naoki, Kuniyoshi, Masami, Yanagita, Kimihiko, Amagase, Hiromasa, Morita, Chie, Sugimoto, Rie, Kato, Masaki, Shimoda, Shinji, Nomura, Hideyuki, Hayashi, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291903/ https://www.ncbi.nlm.nih.gov/pubmed/34374128 http://dx.doi.org/10.1111/jgh.15659 |
Ejemplares similares
-
Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C
por: Ogawa, Eiichi, et al.
Publicado: (2020) -
Development of Hepatocellular Carcinoma in Patients Aged 75–84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals
por: Ogawa, Eiichi, et al.
Publicado: (2020) -
Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study
por: Ogawa, Eiichi, et al.
Publicado: (2022) -
Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: an analysis with real world outcomes from a multicentre cohort in Japan
por: Igarashi, Ataru, et al.
Publicado: (2019) -
Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study
por: Kawano, Akira, et al.
Publicado: (2018)